Journal article Published 2017

Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells

Tomáš Oždian, Dušan Holub, Zuzana Macečková, Lakshman Varanasi, Gabriela Rylová, Jiří Řehulka, Jana Václavková, Hanuš Slavík, Pavel Moudrý, Pawel Znojek, Jarmila Stanková, Juan Bautista De Sanctis, Marián Hajdúch, Petr Džubák

Journal of Proteomics 162, 73-85 (2017)

View on PubMed Cite

2017 Year
28478306 PMID

Cite this publication

OŽDIAN, T., D. HOLUB, Z. MACEČKOVÁ, L. VARANASI, G. RYLOVÁ, J. ŘEHULKA, J. VÁCLAVKOVÁ, H. SLAVÍK, P. MOUDRÝ, P. ZNOJEK, J. STANKOVÁ, J. DE SANCTIS, M. HAJDÚCH, P. DŽUBÁK: Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells. Journal of Proteomics. 2017, 162, 73-85, ISSN: 1874-3919, PMID: 28478306.

Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells

Cite this publication

Details

Authors from IMTM